Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway; Department of Emergency Medicine, Haukeland University Hospital, Bergen, Norway.
Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Int J Infect Dis. 2024 Jun;143:107019. doi: 10.1016/j.ijid.2024.107019. Epub 2024 Apr 4.
This study aimed to describe the microbial aetiology of community-acquired pneumonia (CAP) in adults admitted to a tertiary care hospital and assess the impact of syndromic polymerase chain reaction (PCR) panels on pathogen detection.
Conducted at Haukeland University Hospital, Norway, from September 2020 to April 2023, this prospective study enrolled adults with suspected CAP. We analysed lower respiratory tract samples using both standard-of-care tests and the BIOFIRE® FILMARRAY® Pneumonia Plus Panel (FAP plus). The added value of FAP Plus in enhancing the detection of clinically relevant pathogens, alongside standard-of-care diagnostics, was assessed.
Of the 3238 patients screened, 640 met the inclusion criteria, with 384 confirmed to have CAP at discharge. In these patients, pathogens with proven or probable clinical significance were identified in 312 (81.3%) patients. Haemophilus influenzae was the most prevalent pathogen, found in 118 patients (30.7%), followed by SARS-CoV-2 in 74 (19.3%), and Streptococcus pneumoniae in 64 (16.7%). Respiratory viruses were detected in 186 (48.4%) patients. The use of FAP plus improved the pathogen detection rate from 62.8% with standard-of-care methods to 81.3%.
Pathogens were identified in 81% of CAP patients, with Haemophilus influenzae and respiratory viruses being the most frequently detected pathogens. The addition of the FAP plus panel, markedly improved pathogen detection rates compared to standard-of-care diagnostics alone.
本研究旨在描述成人社区获得性肺炎(CAP)的微生物病因,并评估综合征聚合酶链反应(PCR)检测对病原体检测的影响。
本前瞻性研究于 2020 年 9 月至 2023 年 4 月在挪威豪克兰大学医院进行,纳入疑似 CAP 的成人患者。我们使用标准护理检测和 BIOFIRE® FILMARRAY® Pneumonia Plus 检测(FAP plus)分析下呼吸道样本。评估 FAP plus 与标准护理诊断相结合,对增强检测临床相关病原体的附加价值。
在筛查的 3238 名患者中,有 640 名符合纳入标准,其中 384 名在出院时确诊为 CAP。在这些患者中,有 312 名(81.3%)患者确定或可能与临床相关的病原体。流感嗜血杆菌是最常见的病原体,在 118 名患者中发现(30.7%),其次是 SARS-CoV-2(74 名,19.3%)和肺炎链球菌(64 名,16.7%)。186 名患者(48.4%)检测到呼吸道病毒。使用 FAP plus 将病原体检测率从标准护理方法的 62.8%提高到 81.3%。
在 81%的 CAP 患者中确定了病原体,流感嗜血杆菌和呼吸道病毒是最常检测到的病原体。与标准护理诊断相比,添加 FAP plus 面板显著提高了病原体检测率。